Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacobus Lubsen

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Epidemiology|March 4, 2008
Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratiosMichael T Koller, Theo Stijnen, Ewout W Steyerberg, et al.
Circulation|November 23, 2006
Variable impact of combining fatal and nonfatal end points in heart failure trialsHicham Skali, Marc A Pfeffer, Jacobus Lubsen, et al.
BMC Medical Research Methodology|May 19, 2010
Subgroup effects despite homogeneous heterogeneity test resultsRolf H H Groenwold, Maroeska M Rovers, Jacobus Lubsen, et al.
Journal of Hypertension|February 18, 2005
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trialJacobus Lubsen, Gilbert Wagener, Bridget-Anne Kirwan, et al.
Journal of Clinical Epidemiology|June 19, 2007
Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventionsJacobus Lubsen, Zoltán Vokó, Philip A Poole-Wilson, et al.
Journal of Interventional Cardiology|November 21, 2002
Outcome following percutaneous transluminal coronary angioplasty performed before 1990Samuel F Mpyisi, Brigitte Santos-Eggimann, Jacobus Lubsen, et al.
International Journal of Cardiology|October 11, 2008
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experienceZoltán Vokó, Nicolas Danchin, Sophie de Brouwer, et al.
Cardiovascular Drugs and Therapy|March 23, 2006
Safety of nifedipine GITS in stable angina: the ACTION trialPhilip A Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, et al.
Journal of Cardiac Failure|March 31, 2009
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?Jay Cohn, John G F Cleland, Jacobus Lubsen, et al.
European Heart Journal|June 15, 2007
Clinical course of isolated stable angina due to coronary heart diseasePhilip A Poole-Wilson, Zoltán Vokó, Bridget-Anne Kirwan, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Epidemiology|March 4, 2008
Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratiosMichael T Koller, Theo Stijnen, Ewout W Steyerberg, et al.
Circulation|November 23, 2006
Variable impact of combining fatal and nonfatal end points in heart failure trialsHicham Skali, Marc A Pfeffer, Jacobus Lubsen, et al.
BMC Medical Research Methodology|May 19, 2010
Subgroup effects despite homogeneous heterogeneity test resultsRolf H H Groenwold, Maroeska M Rovers, Jacobus Lubsen, et al.
Journal of Hypertension|February 18, 2005
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trialJacobus Lubsen, Gilbert Wagener, Bridget-Anne Kirwan, et al.
Journal of Clinical Epidemiology|June 19, 2007
Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventionsJacobus Lubsen, Zoltán Vokó, Philip A Poole-Wilson, et al.
Journal of Interventional Cardiology|November 21, 2002
Outcome following percutaneous transluminal coronary angioplasty performed before 1990Samuel F Mpyisi, Brigitte Santos-Eggimann, Jacobus Lubsen, et al.
International Journal of Cardiology|October 11, 2008
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experienceZoltán Vokó, Nicolas Danchin, Sophie de Brouwer, et al.
Cardiovascular Drugs and Therapy|March 23, 2006
Safety of nifedipine GITS in stable angina: the ACTION trialPhilip A Poole-Wilson, Bridget-Anne Kirwan, Zoltán Vokó, et al.
Journal of Cardiac Failure|March 31, 2009
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?Jay Cohn, John G F Cleland, Jacobus Lubsen, et al.
European Heart Journal|June 15, 2007
Clinical course of isolated stable angina due to coronary heart diseasePhilip A Poole-Wilson, Zoltán Vokó, Bridget-Anne Kirwan, et al.
Pageof 4